A phase II study of concurrent chemoradiotherapy with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer

Randall S. Hughes,Alan Sandler,Anshu K. Jain,Afshin Dowlati,Lee S. Schwartzberg,T. Dobbs,Larry Schlabach,Jean Wu,N. J. Muldowney,Hak Choy

A phase II study of concurrent chemoradiotherapy with weekly docetaxel, carboplatin, and radiation therapy followed by consolidation chemotherapy with docetaxel and carboplatin for locally advanced inoperable non-small cell lung cancer

2008

Randall S. Hughes
Alan Sandler
Anshu K. Jain
Afshin Dowlati
Lee S. Schwartzberg
T. Dobbs
Larry Schlabach
Jean Wu
N. J. Muldowney
Hak Choy

7565 The current standard of care for good performance status patients with locally advanced non-small cell lung carcinoma is concurrent chemoradiation, although a clearly superior regimen has not ...

Keywords:

Oncology
Carboplatin
Cell
Phases of clinical research
Pathology
Internal medicine
Radiation therapy
Consolidation Chemotherapy
Chemoradiotherapy
Lung cancer
Medicine
Docetaxel
locally advanced
non small cell

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations